Nizar El Khalili
Psychiatry · Lafayette, INNPI 1861429714
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,250 of the $19,266 with a category attached, or 74.0%. Johnson & Johnson accounts for 92.5% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $12,678 and has fallen 99.7% since, to $34 in 2022. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $114.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$18K
- Lundbeck LLC$272
- AbbVie$235
- Otsuka America Pharmaceutical, Inc.$210
- Alkermes, Inc.$118
- Teva Pharmaceuticals USA, Inc.$76
- plus $543 from 14 others
What the payments were for
- Speaking & faculty fees$14,25074%
- Travel & lodging$2,46613%
- Food & beverage$2,53013%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 71 | $17,813 |
| Lundbeck LLC | 19 | $272 |
| AbbVie(2 entities) | 20 | $235 |
| Otsuka America Pharmaceutical, Inc. | 14 | $210 |
| Alkermes, Inc. | 5 | $118 |
| Teva Pharmaceuticals USA, Inc. | 5 | $76 |
| Shire North American Group Inc | 5 | $75 |
| Avanir Pharmaceuticals, Inc. | 5 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Indivior Inc. | 3 | $50 |
| Neurocrine Biosciences, Inc. | 3 | $44 |
| Noven Therapeutics, LLC | 2 | $41 |
| Sunovion Pharmaceuticals Inc. | 4 | $41 |
| Bausch Health US, LLC | 3 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Neuronetics, Inc. | 1 | $14 |
| OWP Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$16,949
How this compares
$19,266 in reported general payments places this provider in the 95th percentile of 514 psychiatry providers in Indiana.
Other psychiatry in Lafayette
- Steven PaulCarmel$2.9M
- Jay FawverAngola$1.4M
- Suhayl NasrMichigan City$739K
- Christopher BojrabCarmel$713K
- Joseph FanelliMunster$443K
- Eric JaggersJeffersonville$260K
- Larry LambertsonFort Wayne$208K
- Louis CadyNewburgh$135K
- Charles BeasleyIndianapolis$129K
- Muhammad MunirAnderson$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.